Oral Phosphate Binders in Patients with Kidney Failure
2010; Massachusetts Medical Society; Volume: 362; Issue: 14 Linguagem: Inglês
10.1056/nejmra0912522
ISSN1533-4406
AutoresMarcello Tonelli, Neesh Pannu, Braden Manns,
Tópico(s)Magnesium in Health and Disease
ResumoHyperphosphatemia, which is nearly universal in kidney failure, is accompanied by low serum levels of vitamin D and hypocalcemia. Without treatment, severe secondary hyperparathyroidism occurs, which may result in painful fractures, brown tumors, and generalized osteopenia. This article reviews the rationale for treatment with oral phosphate binders, discusses evidence supporting the use of available agents, and suggests an approach for clinical practice.
Referência(s)